NCT00864045View on ClinicalTrials.gov

Sertindole in Asian Patients With Schizophrenia

PHASE3CompletedINTERVENTIONAL
Enrollment

394

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

May 31, 2008

Conditions
Schizophrenia
Interventions
DRUG

Sertindole

Sertindole flexible doses per os, 12, 16 or 20mg/day according to response and tolerability, initially up-titrated from 4mg/day to target dose 16mg/day within the first 16 days

DRUG

Olanzapine

Olanzapine flexible doses per os, 10, 15 or 20mg/day according to response and tolerability, initially up-titrated from 10mg/day to target dose 15mg/day within the first 16 days

Trial Locations (1)

300074

CN001, Beijing

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT00864045 - Sertindole in Asian Patients With Schizophrenia | Biotech Hunter | Biotech Hunter